Alendronate in the treatment of primary hyperparathyroid-related osteoporosis.

被引：0
|
作者：
Parker, CR [1 ]
Blackwell, PJ [1 ]
Hosking, DJ [1 ]
机构：
[1] City Hosp, Div Mineral Metab, Nottingham NG5 1PB, England
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1998年 / 13卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P11
引用
收藏
页码：1508 / 1508
页数：1
相关论文
共 50 条
  • [21] Alendronate in the treatment of osteoporosis
    Adami, S
    AGING-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 10 (02): : 159 - 160
  • [22] Long-term effects of a six month treatment course with oral alendronate in postmenopausal osteoporosis.
    Rossini, M
    Gatti, D
    Zamberlan, N
    Braga, V
    Gerardi, D
    Adami, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S469 - S469
  • [23] Raloxifene treatment of postmenopausal osteoporosis.
    Lufkin, EG
    Whitaker, MD
    Argueta, R
    Caplan, RH
    Nickelsen, T
    Riggs, BL
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : 191 - 191
  • [24] Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis.
    Adachi, JD
    Reginster, J
    Qu, Y
    Siddhanti, S
    Keech, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S379 - S379
  • [25] PRIMARY HYPERPARATHYROIDISM AND OSTEOPOROSIS. THE ROLE OF EXERCISE
    Dionyssiotis, Y.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S82 - S82
  • [26] An open-label extension study of alendronate in elderly women with osteoporosis.
    Harris, ST
    Downs, R
    Bone, H
    Yates, AJ
    Lombardi, A
    Harning, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S468 - S468
  • [27] Estrogens and SERMs in the treatment of osteoporosis.
    Ribot, C
    Tremollieres, F
    Pouilles, JM
    ANNALES DE MEDECINE INTERNE, 2000, 151 (06): : 490 - 496
  • [28] Patient treatment preferences for osteoporosis.
    Fraenkel, L
    Gulanski, B
    Wittink, DR
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S511 - S511
  • [29] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.
    Rizzoli, R
    Roux, C
    Greenspan, S
    Bone, H
    Schnitzer, T
    Watts, N
    Adami, S
    Uebelhart, B
    Peverly, C
    Kaur, A
    Wu, M
    Orloff, J
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S527 - S527
  • [30] The effect of a once-weekly tablet containing alendronate and vitamin D3 for the treatment of osteoporosis.
    Lips, PT
    Recker, RR
    Rosen, CJ
    Bone, H
    Minne, HW
    Callahan, G
    Lamotta, A
    He, W
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S396 - S397
12345